J Grosset

15.5k total citations
258 papers, 10.5k citations indexed

About

J Grosset is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, J Grosset has authored 258 papers receiving a total of 10.5k indexed citations (citations by other indexed papers that have themselves been cited), including 205 papers in Infectious Diseases, 153 papers in Epidemiology and 50 papers in Surgery. Recurrent topics in J Grosset's work include Tuberculosis Research and Epidemiology (175 papers), Mycobacterium research and diagnosis (130 papers) and Cancer therapeutics and mechanisms (40 papers). J Grosset is often cited by papers focused on Tuberculosis Research and Epidemiology (175 papers), Mycobacterium research and diagnosis (130 papers) and Cancer therapeutics and mechanisms (40 papers). J Grosset collaborates with scholars based in France, United States and South Africa. J Grosset's co-authors include Eric L. Nuermberger, William R. Bishai, C. Truffot-Pernot, Sandeep Tyagi, Deepak V. Almeida, Kathy N. Williams, Ian M. Rosenthal, Botao Ji, Nacer Lounis and Tetsuyuki Yoshimatsu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Nature Genetics.

In The Last Decade

J Grosset

242 papers receiving 9.9k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
J Grosset 7.9k 7.2k 2.6k 2.3k 1.1k 258 10.5k
Eric L. Nuermberger 6.6k 0.8× 4.6k 0.6× 1.4k 0.5× 2.5k 1.1× 878 0.8× 169 8.1k
Véronique Dartois 6.6k 0.8× 4.7k 0.6× 1.6k 0.6× 3.8k 1.6× 900 0.8× 202 10.2k
Gail L. Woods 5.1k 0.6× 5.6k 0.8× 1.8k 0.7× 800 0.3× 705 0.6× 196 8.8k
Charles A. Peloquin 7.8k 1.0× 5.9k 0.8× 2.0k 0.8× 1.7k 0.8× 1.0k 0.9× 317 11.7k
Emmanuelle Cambau 4.5k 0.6× 5.0k 0.7× 1.3k 0.5× 2.2k 1.0× 1.7k 1.5× 148 8.3k
Gerald Medoff 4.7k 0.6× 4.3k 0.6× 1.3k 0.5× 1.8k 0.8× 244 0.2× 175 9.7k
Martin J. Boeree 5.4k 0.7× 4.9k 0.7× 1.5k 0.6× 910 0.4× 338 0.3× 165 7.4k
Tawanda Gumbo 5.5k 0.7× 4.1k 0.6× 821 0.3× 1.1k 0.5× 1.1k 1.0× 197 7.6k
Leonid Heifets 3.8k 0.5× 3.8k 0.5× 836 0.3× 1.2k 0.5× 575 0.5× 98 5.7k
Patrick J. Brennan 3.4k 0.4× 4.0k 0.6× 912 0.3× 2.0k 0.9× 728 0.7× 90 10.8k

Countries citing papers authored by J Grosset

Since Specialization
Citations

This map shows the geographic impact of J Grosset's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Grosset with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Grosset more than expected).

Fields of papers citing papers by J Grosset

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Grosset. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Grosset. The network helps show where J Grosset may publish in the future.

Co-authorship network of co-authors of J Grosset

This figure shows the co-authorship network connecting the top 25 collaborators of J Grosset. A scholar is included among the top collaborators of J Grosset based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Grosset. J Grosset is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Omansen, Till F., Deepak V. Almeida, Paul J. Converse, et al.. (2018). High-Dose Rifamycins Enable Shorter Oral Treatment in a Murine Model of Mycobacterium ulcerans Disease. Antimicrobial Agents and Chemotherapy. 63(2). 13 indexed citations
2.
Tyagi, Sandeep, Nicole C. Ammerman, Si-Yang Li, et al.. (2015). Clofazimine shortens the duration of the first-line treatment regimen for experimental chemotherapy of tuberculosis. Proceedings of the National Academy of Sciences. 112(3). 869–874. 91 indexed citations
3.
Ahmad, Zahoor, Mostafa Fraig, Michael L. Pinn, et al.. (2011). Effectiveness of tuberculosis chemotherapy correlates with resistance to Mycobacterium tuberculosis infection in animal models. Journal of Antimicrobial Chemotherapy. 66(7). 1560–1566. 19 indexed citations
4.
Ahmad, Zahoor, Eric Nuermberger, Rokeya Tasneen, et al.. (2010). Comparison of the 'Denver regimen' against acute tuberculosis in the mouse and guinea pig. Journal of Antimicrobial Chemotherapy. 65(4). 729–734. 42 indexed citations
5.
Tasneen, Rokeya, Sandeep Tyagi, Kathy N. Williams, J Grosset, & Eric L. Nuermberger. (2008). Enhanced Bactericidal Activity of Rifampin and/or Pyrazinamide When Combined with PA-824 in a Murine Model of Tuberculosis. Antimicrobial Agents and Chemotherapy. 52(10). 3664–3668. 77 indexed citations
6.
Williams, Kathy N., C. Kendall Stover, Tong Zhu, et al.. (2008). Promising Antituberculosis Activity of the Oxazolidinone PNU-100480 Relative to That of Linezolid in a Murine Model. Antimicrobial Agents and Chemotherapy. 53(4). 1314–1319. 160 indexed citations
7.
Grosset, J. (2008). Dose-Ranging Comparison of Rifampin and Rifapentine in Combination with Isoniazid and Pyrazinamide in the Mouse Model of Tuberculosis. 46th Annual Meeting. 4 indexed citations
8.
Alffenaar, Jan‐Willem C., Willemien A. Nienhuis, Femke de Velde, et al.. (2008). Pharmacokinetics of Rifampicin and Clarithromycin in Patients Treated for Mycobacterium ulcerans Infection in Ghana. 46th Annual Meeting. 1 indexed citations
9.
Almeida, Deepak V., Eric Nuermberger, Sandeep Tyagi, William R. Bishai, & J Grosset. (2007). In Vivo Validation of the Mutant Selection Window Hypothesis with Moxifloxacin in a Murine Model of Tuberculosis. Antimicrobial Agents and Chemotherapy. 51(12). 4261–4266. 31 indexed citations
10.
Rosenthal, Ian M., Kathy N. Williams, Sandeep Tyagi, et al.. (2005). Weekly Moxifloxacin and Rifapentine Is More Active Than the Denver Regimen in Murine Tuberculosis. American Journal of Respiratory and Critical Care Medicine. 172(11). 1457–1462. 42 indexed citations
11.
Nuermberger, Eric, Sandeep Tyagi, Kathy N. Williams, et al.. (2005). Rifapentine, Moxifloxacin, or DNA Vaccine Improves Treatment of Latent Tuberculosis in a Mouse Model. American Journal of Respiratory and Critical Care Medicine. 172(11). 1452–1456. 58 indexed citations
12.
Nuermberger, Eric, Tetsuyuki Yoshimatsu, Sandeep Tyagi, et al.. (2004). Moxifloxacin-containing Regimens of Reduced Duration Produce a Stable Cure in Murine Tuberculosis. American Journal of Respiratory and Critical Care Medicine. 170(10). 1131–1134. 167 indexed citations
13.
Nuermberger, Eric L., Tetsuyuki Yoshimatsu, Sandeep Tyagi, et al.. (2003). Moxifloxacin-containing Regimen Greatly Reduces Time to Culture Conversion in Murine Tuberculosis. American Journal of Respiratory and Critical Care Medicine. 169(3). 421–426. 242 indexed citations
14.
Grosset, J, et al.. (2002). Épidémiologie mondiale de la tuberculose et de la résistance aux antibiotiques antituberculeux. 153(2). 107–112. 3 indexed citations
15.
Honoré, Nadine, Paul Roche, J Grosset, & Stewart T. Cole. (2001). A method for rapid detection of rifampicin-resistant isolates ofMycobacterium leprae. Leprosy Review. 72(4). 441–8. 15 indexed citations
16.
Enarson, Donald A., J Grosset, Alwyn Mwinga, et al.. (1995). The challenge of tuberculosis: statements on global control and prevention. The Lancet. 346(8978). 809–810. 34 indexed citations
17.
Colston, M. Joseph, G.A. Ellard, J Grosset, et al.. (1988). Characteristics of the multiplication of dapsone-resistant strains of Mycobacterium leprae in mice. Leprosy Review. 59(1). 5–10.
18.
Grosset, J. (1988). New approaches in antimycobacterial chemotherapy. Drugs of today. 24(5). 291–301. 4 indexed citations
19.
Grosset, J, et al.. (1970). La thiacétazone (Tb-1): données expérimentales et cliniques récentes.. 26. 107–153. 2 indexed citations
20.
Canetti, G, et al.. (1964). [INCIDENCE AND CHARACTERISTICS OF PRIMARY RESISTANCE IN 2144 CASES OF UNTREATED PULMONARY TUBERCULOSIS FROM DIFFERENT REGIONS OF FRANCE. (PRELIMINARY REPORT OF THE CENTRE D'ETUDE SUR LA R'ESISTANCE PRIMAIRE)].. PubMed. 28. 1115–58. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eric L. Nuermberger Breakdown of academic impact, for papers by Véronique Dartois Breakdown of academic impact, for papers by Gail L. Woods Breakdown of academic impact, for papers by Charles A. Peloquin Breakdown of academic impact, for papers by Emmanuelle Cambau Breakdown of academic impact, for papers by Gerald Medoff Breakdown of academic impact, for papers by Martin J. Boeree Breakdown of academic impact, for papers by Tawanda Gumbo Breakdown of academic impact, for papers by Leonid Heifets Breakdown of academic impact, for papers by Patrick J. Brennan
Rankless by CCL
2026